Results
2533
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,533 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
LLY | US$924.56 | 2.2% | 68.2% | US$832.4b | US$995.42 | PE113.4x | E28.5% | 0.6% | Pharmaceuticals & Biotech | ||
UNH | US$576.31 | -0.7% | 14.4% | US$531.1b | US$623.11 | PE37.7x | E23.4% | 1.5% | Healthcare | ||
JNJ | US$160.60 | -3.3% | 2.2% | US$391.9b | US$171.32 | PE23.6x | E7.2% | 3.1% | Pharmaceuticals & Biotech | ||
ABBV | US$191.26 | -0.9% | 24.9% | US$341.8b | US$196.54 | PE63.8x | E25.3% | 3.2% | Pharmaceuticals & Biotech | ||
MRK | US$114.73 | -3.3% | 10.4% | US$291.4b | US$139.03 | PE21.2x | E14.4% | 2.7% | Pharmaceuticals & Biotech | ||
AZN | UK£115.66 | -2.4% | 4.0% | UK£179.3b | UK£138.09 | PE37.1x | E16.4% | 1.9% | Pharmaceuticals & Biotech | ||
TMO | US$599.78 | -1.7% | 20.4% | US$233.7b | US$647.76 | PE36.8x | E10.6% | 0.3% | Pharmaceuticals & Biotech | ||
DHR | US$267.88 | -1.5% | 8.3% | US$198.0b | US$288.05 | PE47.7x | E14.3% | 0.4% | Pharmaceuticals & Biotech | ||
ABT | US$112.61 | -2.0% | 17.9% | US$197.2b | US$124.12 | PE35.4x | E11.7% | 2.0% | Healthcare | ||
AMGN | US$312.86 | -6.0% | 16.3% | US$177.8b | US$325.55 | PE53.7x | E23.8% | 2.9% | Pharmaceuticals & Biotech | ||
ISRG | US$484.39 | 0.5% | 66.2% | US$172.1b | US$483.95 | PE82.2x | E12.5% | n/a | Healthcare | ||
PFE | US$28.93 | -2.8% | -9.9% | US$167.2b | US$33.66 | PS3x | E32.9% | 5.8% | Pharmaceuticals & Biotech | ||
SYK | US$359.50 | -0.5% | 34.9% | US$137.6b | US$372.59 | PE39.7x | E10.8% | 0.9% | Healthcare | ||
BSX | US$83.50 | 1.1% | 60.3% | US$123.0b | US$87.26 | PE67.3x | E20.9% | n/a | Healthcare | ||
ELV | US$520.49 | -3.5% | 17.0% | US$122.3b | US$603.07 | PE18x | E11.6% | 1.3% | Healthcare | ||
VRTX | US$461.76 | -2.6% | 32.1% | US$119.5b | US$509.82 | PS11.5x | E46.4% | n/a | Pharmaceuticals & Biotech | ||
MDT | US$89.39 | 1.4% | 14.3% | US$115.1b | US$94.62 | PE29.2x | E11.2% | 3.1% | Healthcare | ||
REGN | US$1,031.15 | -9.5% | 23.9% | US$112.9b | US$1,157.07 | PE25.8x | E10.5% | n/a | Pharmaceuticals & Biotech | ||
GILD | US$82.21 | -2.0% | 8.8% | US$104.3b | US$83.54 | PE97.1x | E36.0% | 3.7% | Pharmaceuticals & Biotech | ||
HCA | US$405.11 | 1.3% | 63.8% | US$103.7b | US$396.60 | PE18.2x | E6.3% | 0.7% | Healthcare | ||
BMY | US$49.95 | 0.4% | -13.7% | US$103.3b | US$53.43 | PS2.2x | E49.0% | 4.8% | Pharmaceuticals & Biotech | ||
CI | US$348.86 | -1.8% | 20.9% | US$98.7b | US$398.29 | PE26.3x | E19.4% | 1.6% | Healthcare | ||
CSL | AU$286.71 | -2.9% | 13.8% | AU$138.8b | AU$313.24 | PE36.1x | E13.0% | 1.3% | Pharmaceuticals & Biotech | ||
ZTS | US$191.53 | -2.5% | 9.6% | US$87.8b | US$213.12 | PE37x | E10.2% | 0.9% | Pharmaceuticals & Biotech |